These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Ligation of hepatic artery combined with radiotherapy in the treatment of unresectable primary liver carcinoma].
    Author: Li GH.
    Journal: Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):370-2. PubMed ID: 3004857.
    Abstract:
    The ligation of hepatic artery combined with radiotherapy is effective in the treatment of unresectable liver carcinoma. Our data show that some of the lesions, upon ligation of hepatic artery, underwent shrinkage and became darkened in color, were designated as "hypervascular type". The others which did not give these responses were designated as "oligovascular type". Yet both belonged to the hepatocellular carcinoma pathologically. In this series the total response rate was 71.4% (10/14). There were 3 patients who had complete regression. The 6-month survival rate was 85.7% (12/14), the one-year, 57.1% (8/14), and the 2-year, 21.4% (3/14). The median survival interval was 14 months (ranging from 2-36 months). The "mass type" which was localized and "hypervascular" responded well to treatment. The application of radiotherapy according to the location and the size of the tumor after the ligation of hepatic artery may be able to improve the result and reduce the side effects of irradiation.
    [Abstract] [Full Text] [Related] [New Search]